Iss Pyaar - Ko Kya Naam Doon 3

Unlike its predecessors which focused on the "enemies-to-lovers" trope within wealthy families, IPKKND 3 introduces a dark, high-stakes medical-legal drama wrapped in a love story.

| Feature | IPKKND 1 & 2 | IPKKND 3 | | --- | --- | --- | | | Family honor, pride, and misunderstandings | Corporate crime, medical ethics, and legal thriller | | Tone | Intense romance with dramatic twists | Dark, suspenseful, with psychological depth | | Setting | Mansions, weddings, traditional homes | Hospitals, courtrooms, corporate offices | | Lead Dynamic | Arrogant businessman vs. cheerful small-town girl | Morally grey lawyer vs. idealistic doctor | iss pyaar ko kya naam doon 3

Enter (played by Mohit Malik ), a ruthless, morally ambiguous corporate lawyer hired by the pharma company to cover up the crimes. Kabir is initially presented as the antagonist—cold, calculating, and willing to destroy evidence to protect his client. The episode ends with a shocking twist: Anjali discovers that Kabir is not just her legal opponent but a man from her past whom she once loved and believed to be dead. idealistic doctor | Enter (played by Mohit Malik

As of April 2026, only the pilot episode has aired. Due to the experimental nature and the franchise's legacy, the production team (under StarPlus) has not yet announced a full season order. Viewer response on social media and streaming metrics on Disney+ Hotstar will determine whether the show continues as a limited series or a full daily soap. As of April 2026, only the pilot episode has aired

Critics praised the show for tackling real-world issues (pharmaceutical corruption) and for its high production values, but questioned whether it should retain the Iss Pyaar Ko Kya Naam Doon title, given the stark departure from the original romantic formula.

The pilot episode centers on (played by Mahima Makwana ), a dedicated and idealistic young doctor working in a government hospital in Mumbai. Her life turns upside down when a series of mysterious patient deaths leads her to suspect foul play by a powerful pharmaceutical corporation.